rs115466848
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001853.4(COL9A3):c.792+19G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00202 in 1,612,204 control chromosomes in the GnomAD database, including 66 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.011 ( 43 hom., cov: 33)
Exomes 𝑓: 0.0011 ( 23 hom. )
Consequence
COL9A3
NM_001853.4 intron
NM_001853.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.356
Publications
2 publications found
Genes affected
COL9A3 (HGNC:2219): (collagen type IX alpha 3 chain) This gene encodes one of the three alpha chains of type IX collagen, the major collagen component of hyaline cartilage. Type IX collagen, a heterotrimeric molecule, is usually found in tissues containing type II collagen, a fibrillar collagen. Mutations in this gene are associated with multiple epiphyseal dysplasia type 3. [provided by RefSeq, Jan 2010]
COL9A3 Gene-Disease associations (from GenCC):
- epiphyseal dysplasia, multiple, 3Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, Illumina, G2P, Labcorp Genetics (formerly Invitae)
- Stickler syndromeInheritance: AR Classification: DEFINITIVE, STRONG, LIMITED Submitted by: Ambry Genetics, Genomics England PanelApp, ClinGen
- Stickler syndrome, type 6Inheritance: AR Classification: DEFINITIVE, STRONG, LIMITED Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- multiple epiphyseal dysplasia due to collagen 9 anomalyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- autosomal recessive Stickler syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 20-62826839-G-A is Benign according to our data. Variant chr20-62826839-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 258433.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0111 (1697/152246) while in subpopulation AFR AF = 0.0377 (1566/41530). AF 95% confidence interval is 0.0362. There are 43 homozygotes in GnomAd4. There are 805 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 43 AD,AR gene
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| COL9A3 | ENST00000649368.1 | c.792+19G>A | intron_variant | Intron 15 of 31 | NM_001853.4 | ENSP00000496793.1 | ||||
| COL9A3 | ENST00000463487.2 | n.500+19G>A | intron_variant | Intron 7 of 10 | 5 | |||||
| COL9A3 | ENST00000489045.5 | n.*19G>A | downstream_gene_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.0111 AC: 1689AN: 152128Hom.: 43 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
1689
AN:
152128
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00293 AC: 724AN: 247252 AF XY: 0.00222 show subpopulations
GnomAD2 exomes
AF:
AC:
724
AN:
247252
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00106 AC: 1553AN: 1459958Hom.: 23 Cov.: 32 AF XY: 0.000889 AC XY: 646AN XY: 726296 show subpopulations
GnomAD4 exome
AF:
AC:
1553
AN:
1459958
Hom.:
Cov.:
32
AF XY:
AC XY:
646
AN XY:
726296
show subpopulations
African (AFR)
AF:
AC:
1176
AN:
33470
American (AMR)
AF:
AC:
123
AN:
44694
Ashkenazi Jewish (ASJ)
AF:
AC:
1
AN:
26124
East Asian (EAS)
AF:
AC:
27
AN:
39694
South Asian (SAS)
AF:
AC:
6
AN:
86214
European-Finnish (FIN)
AF:
AC:
0
AN:
51862
Middle Eastern (MID)
AF:
AC:
11
AN:
5766
European-Non Finnish (NFE)
AF:
AC:
72
AN:
1111796
Other (OTH)
AF:
AC:
137
AN:
60338
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
89
179
268
358
447
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
38
76
114
152
190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0111 AC: 1697AN: 152246Hom.: 43 Cov.: 33 AF XY: 0.0108 AC XY: 805AN XY: 74448 show subpopulations
GnomAD4 genome
AF:
AC:
1697
AN:
152246
Hom.:
Cov.:
33
AF XY:
AC XY:
805
AN XY:
74448
show subpopulations
African (AFR)
AF:
AC:
1566
AN:
41530
American (AMR)
AF:
AC:
99
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3470
East Asian (EAS)
AF:
AC:
1
AN:
5188
South Asian (SAS)
AF:
AC:
0
AN:
4824
European-Finnish (FIN)
AF:
AC:
0
AN:
10620
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
13
AN:
67990
Other (OTH)
AF:
AC:
18
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
91
181
272
362
453
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
5
AN:
3478
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Intervertebral disc disorder;C1832998:Epiphyseal dysplasia, multiple, 3 Benign:1
May 11, 2022
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.